Send this page to a friend
Message :
This link has been sent to you from Simbec website.

Enter the characters shown in the image.

1866 - Male, 18 - 55

Information file

18 - 55
Smoking habits
Non / Ex-smoker only

Body Mass Index (BMI)

Return Visits


A study to investigate a new drug being developed for the treatment of Type 2 Diabetes Mellitus.

This study consists of a Screening Visit (to confirm your eligibility to enter the study).

Two overnight stays from Day -1 to Day 2 and Day 28 to Day 29

28 daily outpatient visits.

Post Study Follow-Up visit

This study is for Type 2 Diabetic (T2D) Patients (on Metformin only)


Please note

Study dates and availability may change at any time. There is no guarantee that these studies will still be available or that the dates will be the same when you contact our call centre. We do our best to ensure that the information published is up-to-date.

Information about the medication involved in the study is not provided on this Web site to respect the industry confidentiality. For more information about a specific study, please contact one of our call centre agents at 0800 691995.

Please note that during the in-house portion of the study you are expected to remain at our clinic throughout the entire duration of the stay. Although you are free to withdraw your participation at any time during the study, leaving the premises before the end of the intended stay, will result in the termination of your participation in the study.

Give us a call

Simply contact one of our recruitment staff who will be happy to take you through the initial process of joining our panel of volunteers.

0800 691995

By e-mail